Primed for the Kill: Occupying BCL-2 to Target Death in Acute Myeloid Leukaemia

BioDiscovery
doi 10.7750/biodiscovery.2012.6.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pensoft Publishers

Related search

SOX12: A Novel Potential Target for Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Acute Aleukaemic Myeloid Leukaemia

BMJ
1943English

Prognosis in Acute Myeloid Leukaemia.

BMJ
1981English

Cord Blood Transplant for Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Combining Bh3-Mimetics to Target Both BCL-2 and McL1 Has Potent Activity in Pre-Clinical Models of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Inhibition of CHK1 Enhances Cell Death Induced by the BCL-2-Selective Inhibitor ABT-199 in Acute Myeloid Leukemia Cells

Oncotarget
Oncology
2016English

Novel Therapies for Children With Acute Myeloid Leukaemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Lineage Switch From Acute Myeloid Leukaemia to T-Cell/Myeloid Mixed Phenotype Acute Leukaemia: First Report of an Adult Case

American Journal of Hematology
Hematology
2018English

Razoxane in Treatment of Acute Myeloid Leukaemia.

BMJ
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy